In focus · trending topic

non-alcoholic steatohepatitis

13 stories · following the connections

Metacrine Broadens Management Team with Two Key Hires

By Nasdaq OMXApr 17, 2018, 12:01 PM UTC

Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference

By Nasdaq OMXApr 2, 2018, 2:20 PM UTC

Immuron Granted US Patent for NASH Treatment

By Nasdaq OMXNov 15, 2017, 2:00 PM UTC

Clarification: Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update

By Nasdaq OMXAug 18, 2017, 12:30 PM UTC

Galectin Therapeutics Announces Important Milestones towards Completion of NASH CX Trial

By Nasdaq OMXJun 13, 2017, 12:30 PM UTC

Galectin Therapeutics Reports 2017 First Quarter Financial Results and Provides Business Update

By Nasdaq OMXMay 15, 2017, 12:30 PM UTC

Galectin Therapeutics Receives Notice of Japanese Decision to Grant a Composition of Matter Patent for GR-MD-02

By Nasdaq OMXApr 25, 2017, 12:02 PM UTC

Galectin Therapeutics Receives Notice of Japanese Decision to Grant a Composition of Matter Patent for GR-MD-02

By Nasdaq OMXApr 25, 2017, 12:02 PM UTC